Literature DB >> 4106555

Undegraded -globulin for intravenous therapy. A new preparation of immune serum globulin for intravenous administration.

W Stephan, M Hainski, J H Payne, G A Ordonez, E Shanbrom.   

Abstract

Mesh：

Substances：

Year:  1971        PMID： 4106555     DOI： 10.1111/j.1423-0410.1971.tb01827.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN： 0042-9007            Impact factor:   2.144


× No keyword cloud information.
  3 in total

1.  Clinical trials of sulfonated immunoglobulin preparation for intravenous administration. II. Adverse reactions.

Authors:  S Matsumoto; N Kobayashi; N Gohya
Journal:  Eur J Pediatr       Date:  1981-05       Impact factor: 3.183

2.  Clinical trial of sulfonated immunoglobulin preparation for intravenous administration. I. Replacement therapy for primary immunodeficiency syndromes.

Authors:  N Kobayashi; N Gohya; S Matsumoto
Journal:  Eur J Pediatr       Date:  1981-05       Impact factor: 3.183

3.  Intravenous immunoglobulin therapy for antibody deficiency.

Authors:  M T Nolte; B Pirofsky; G A Gerritz; B Golding
Journal:  Clin Exp Immunol       Date:  1979-05       Impact factor: 4.330
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.